EUVIMEDEUVIMED entdecken
Crossref

L26/P-496 Inflammation disrupts insulin and progesterone signalling compromising endometrial decidualization

A. Villalba, A. Ana Belén, N. Medrano, I. Ortega Baño, A. Bas-Rivas, A. Faus, A. Pellicer, H. Ferrero

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.829 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Villalba und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does acute inflammation induce insulin resistance in human endometrial stromal cells, and how does this affect the decidualization process? Summary answer Inflammation disrupts insulin and progesterone signalling, significantly impairing decidualization in human endometrial stromal cells that could potentially compromise the endometrial receptivity. What is known already Insulin resistance is increasingly recognized as a prevalent metabolic condition in women with subfertility, frequently associated with impaired implantation and poor reproductive outcomes. Emerging evidence indicates that insulin resistance is closely linked to an inflammatory uterine environment. However, the implications of this interaction for endometrial function remain poorly understood. In this regard, progesterone resistance and impaired insulin signalling are currently viewed as independent hallmarks of endometrial dysfunction and are often studied independently. Based on this, this study examined the potential role of a pro-inflammatory environment to disrupts insulin and progesterone signalling, and the impact of this interplay on endometrial function. Study design, size, duration This study utilized the human endometrial stromal cell line (hESC, ATCC CRL-4003). Cells were cultured to 80% confluence and treated with 0 ng/ml (Control group) and 1000 ng/ml Lipopolysaccharide (LPS group) to induce acute inflammation (4 and 24 hours). For decidualization experiments, LPS treatment was maintained throughout the entire 6-day secretory differentiation protocol. Total RNA was extracted and gene expression was analyzed via RT-qPCR. Experiments were performed with six biological replicates to ensure statistical robustness. Participants/materials, setting, methods hESCs were decidualized using a hormonal cocktail containing estradiol (E2), progesterone (P4), and cAMP. To evaluate the inflammatory impact on metabolic and hormonal pathways, we quantified the expression of key insulin signalling mediators (INSR, IRS1/2, FOXO1, GLUT1, MAPK8/JNK), progesterone receptor B (PRB) and progesterone-responsive gene HSD17B2, acute inflammatory markers (NFKB, IL-6, IL8, COX2) and HIF1A by RT-qPCR. Data were normalized to RPL19 and analyzed using Mann-Whitney t-tests to determine statistical significance (p-value ≤ 0.05). Main results and the role of chance LPS treatment successfully induced an early acute inflammatory response in 4 and 24 hours. This was also observed by the end of secretory phase, characterized by increased NFKB activity compared to control group (Fold Change [FC]: 9.1) and subsequent overexpression of IL6 (FC: 23.4), IL8 (FC: 432.0), and COX2 (FC: 82.2). We observed that the NFKB activation led to the upregulation of MAPK8/JNK (FC: 3.1). Consequently, this upregulation inhibited IRS1 (FC: 0.1) and IRS2 (FC: 0.5). Despite an observed overexpression of PRB (FC: 22.4), its transcriptional targets IRS1/2 and HSD17B2 (FC: 0.1) were paradoxically repressed in LPS, indicating a state of progesterone resistance and functional PRB blockade at the translocation level. As a compensatory response to impaired insulin signaling, HESCs exhibited an increase in INSR (FC: 30.3) and FOXO1 (FC: 32.3) in LPS group. This metabolic shift, further reinforced by NFKB-driven HIF1A activation (FC: 24.8), together with FOXO1, resulted in the overexpression of GLUT1 (FC: 2.1) in LPS group. Ultimately, this complex hormonal and metabolic dysregulation culminated in defective decidualization, evidenced by the significantly altered expression of differentiation markers, such as SPP1 (FC: 4.2), HSD17B2 (FC: 0.1), and PAEP (FC: 0.3) in LPS compared to control group. Limitations, reasons for caution The use of an in vitro system based on a cell line, which may not fully replicate the complexity of the human endometrium. Additionally, the dynamic metabolic fluctuations of the in vivo setting are missing. Future studies using primary cells are necessary to validate these molecular mechanisms. Wider implications of the findings By identifying how progesterone resistance and insulin signalling disruption impact on endometrial decidualization, we point to a new therapeutic target. This is crucial for developing personalized treatments for infertility, potentially improving implantation in patients with uterine diseases related to a pro-inflammatory environment, and metabolic alterations, like endometriosis or adenomyosis. Trial registration number No

Zitieren

APA

Villalba, A., Belén, A. A., Medrano, N., Baño, I. O., Bas-Rivas, A., Faus, A., Pellicer, A., & Ferrero, H. (2026). L26/P-496 Inflammation disrupts insulin and progesterone signalling compromising endometrial decidualization. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.829

Vancouver

Villalba A, Belén AA, Medrano N, Baño IO, Bas-Rivas A, Faus A, et al. L26/P-496 Inflammation disrupts insulin and progesterone signalling compromising endometrial decidualization. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.829

BibTeX
@article{Villalba2026,
  author = {Villalba, A. and Belén, A. Ana and Medrano, N. and Baño, I. Ortega and Bas-Rivas, A. and Faus, A. and Pellicer, A. and Ferrero, H.},
  title = {L26/P-496 Inflammation disrupts insulin and progesterone signalling compromising endometrial decidualization},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.829}
}
Kostenlos starten →